Hopp til innhold
NHI.no
Annonse

Astma hos idrettsutøvere: Diagnosen

Innhold i artikkelen

Korrekt diagnose er viktig, ikke bare i forbindelse med søknad om medisinsk fritak. Det er også viktig for å sikre at utøveren får best mulig behandling. Erfaring fra undersøkelser tyder på at mange idrettsutøvere er underbehandlet og av den grunn forhindres fra å nå toppresultater. Motsatt er det enkelte som får behandling mot astma eller anstrengelsesutløst bronkospasme, uten å ha en slik sykdom. Det er ikke grunn til å tro at slik bruk øker prestasjonsevnen. Det som er avgjørende, er et godt samarbeid mellom idrettsutøveren, behandlingsansvarlig medisinsk personell, treningsansvarlig, idrettsforbundet og eventuelt Antidoping Norge .

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Bronkospasme, anstrengelsesutløst . Referanselisten for dette dokumentet vises nedenfor

  1. Smoliga JM, Mohseni ZS, Berwager JD, et al. Common causes of dyspnoea in athletes: a practical approach for diagnosis and management. Breathe (Sheff) 2016 Jun; 12(2): e22-37. pmid:27408644 PubMed
  2. Weiler JM, Anderson SD, Randolph C, et al; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. Ann Allergy Asthma Immunol 2010;105(suppl):S1-47
  3. Smoliga JM, Weiss P, Rundell KW. Exercise induced bronchoconstriction in adults: evidence based diagnosis and management. BMJ 2016; 352: h6951. pmid:26762594 PubMed
  4. Weiler JM, Brannan JD, Randolph CC, Hallstrand TS, Parsons J, Silvers W, Storms W, Zeiger J, Bernstein DI, Blessing-Moore J, Greenhawt M, Khan D, Lang D, Nicklas RA, Oppenheimer J, Portnoy JM, Schuller DE, Tilles SA, Wallace D. Exercise-induced bronchoconstriction update-2016. J Allergy Clin Immunol. 2016 Nov;138(5):1292-1295.e36. Epub 2016 Sep 21. PMID: 27665489. PubMed
  5. Weiss P, Rundell KW. Imitators of exercise-induced bronchoconstriction. Allergy Asthma Clin Immunol. 2009; 5(1): 7. pmid:20016690 PubMed
  6. de Aguiar KB, Anzolin M, Zhang L. Global prevalence of exercise-induced bronchoconstriction in childhood: A meta-analysis. Pediatr Pulmonol 2018; Jan 24: epub ahead of print. pmid:29364581 PubMed
  7. Molis MA, Molis WE. Exercise-induced bronchospasm. Sports Health 2010 Jul; 2(4): 311-17. doi:10.1177/1941738110373735 DOI
  8. Wilber RL, Rundell KW, Szmedra L, Jenkinson DM, Im J, Drake SD. Incidence of exercise-induced bronchospasm in Olympic winter sport athletes. Med Sci Sports Exerc 2000; 32: 732-7. PubMed
  9. Parsons JP, Mastronarde JG. Exercise-induced bronchoconstriction in athletes. Chest 2005; 128: 3966-74. PubMed
  10. Weiler JM, Hallstrand TS, Parsons JP, et al. Improving screening and diagnosis of exercise-induced bronchoconstriction: a call to action. J Allergy Clin Immunol Pract 2014; 2(3): 275-80. pmid:24811017 PubMed
  11. Parsons JP, Hallstrand TS, Mastronarde JG, et al. An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Resp Crit Care Med 2013. doi:10.1164/rccm.201303-0437ST DOI
  12. Carlsen KH, Anderson SD, Bjermer L, et al. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy 2008 Apr; 63(4): 387-403. pmid:18315727 PubMed
  13. Pasnick SD, Carlos WG 3rd, Arunachalam A, et al. Exercise-induced bronchoconstriction. Ann Am Thorac Soc 2014 Dec; 11(10): 1651-2. pmid:25549031 PubMed
  14. Langhammer A, Jakobsen A, Sjaastad G, Østrem A. Astmaveileder for allmennpraksis. 2022. www.lungeripraksis.no
  15. Røksund OD, Heimdal JH, Clemm H. Exercise inducible laryngeal obstruction: diagnostics and management. Paediatr Respir Rev 2016 ; Jul 18: S1526-0542. doi:10.1016/j.prrv.2016.07.003 DOI
  16. Røksund O, Clemm H. Exercise indusert laryngeal obstruksjon. Generell veileder i pediatri. Sist faglig oppdatert 01.01.2017. www.helsebiblioteket.no
  17. Nielsen EW, Hull JH, Backer V. High prevalence of exercise-induced laryngeal obstruction in athletes. Med Sci Sports Exerc 2013 Nov; 45(11): 2030-5. pmid:23657163 PubMed
  18. Krafczyk MA, Asplund CA. Exercise-induced bronchoconstriction: diagnosis and management. Am Fam Physician 2011: 84; 427-34.
  19. Clemm H, Røksund O. Provokasjonstest for anstrengelsesutløst bronkokonstriksjon. Generell veileder i pediatri. Sist faglig oppdatert 01.01.2017. www.helsebiblioteket.no
  20. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2025. Updated May 2025. Available from www.ginasthma.org ginasthma.org
  21. Sonna LA, Angel KC, Sharp MA, Knapik JJ, Patton JF, Lilly CM. The prevalence of exercise-induced bronchospasm among US Army recruits and its effects on physical performance. Chest 2001;119:1676-84. PubMed
  22. Stickland MK, Rowe BH, Spooner CH, et. al. Effect of warm-up exercise on exercise-induced bronchoconstriction. Med Sci Sports Exerc 2012 Mar; 44(3): 383-91. pmid:21811185 PubMed
  23. Beuther DA, Martin RJ. Efficacy of a heat exchanger mask in cold exercise-induced asthma. Chest 2006; 129: 1188-93. PubMed
  24. Antidoping Norge www.antidoping.no
  25. Philip G, Pearlman DS, Villarán C, et al. Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction. Chest 2007; 132: 875-83. PubMed
  26. Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998;339:147-52. New England Journal of Medicine
  27. Edelman JM, Turpin JA, Bronsky EA, et al. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group. Ann Intern Med 2000; 132: 97-104. Annals of Internal Medicine
  28. FDA. Press Announcements. FDA Requires Stronger Warning About Risk of Neuropsychiatric Events Associated with Asthma and Allergy Medication Singulair and Generic Montelukast. March 2020. www.fda.gov
Annonse
Annonse